Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Toabo, Ordinary Profit Forecast for Last Fiscal Year Revised Downward by 1%
3204 Toabo Corporation 【J-GAAP】
Guidance Update ReportToabo Corporation <3204> [TSE Std] announced a performance revision after the market closed on January 27th (15:30). The consolidated ordinary profit forecast for the fiscal year ending December 2025 has decreased 1.4%, from the previous forecast of 730 million yen to 720 million yen (compared to 857 million yen in the previous period), leading to an increase in the profit decline rate from 14.8% to 16.0%. However, the full-year forecast for consolidated net income has been revised upward 30.0%, from the previous forecast of 500 million yen to 650 million yen (compared to 799 million yen in the previous period), and the declining rate is expected to decrease from 37.4% to 18.6%.
Based on the downwardly revised full-year plan announced by the company, our calculation indicates that the July to December period (second half) consolidated ordinary profit has decreased 4.4%, from the previous forecast of 225 million yen to 215 million yen (compared to 423 million yen in the same period of the previous year), leading to an increase in the profit decline rate from 46.8% to 49.2%.
Kabutan News
Guidance Update
Second Half Update
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jul - Dec, 2025 Prev | 10,725 | 388 | 225 | 249 | 28.2 | 14 | Aug 8, 2025 | J-GAAP |
| Jul - Dec, 2025 New | 8,625 | 148 | 215 | 399 | 45.3 | 14 | Jan 27, 2026 | J-GAAP |
| Revision Rate | -19.6% | -61.9% | -4.4% | +60.2% | +60.6% |
Full Year Update
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Dec, 2025 Prev | 19,500 | 800 | 730 | 500 | 56.6 | 14 | Feb 13, 2025 | J-GAAP |
| Dec, 2025 New | 17,400 | 560 | 720 | 650 | 73.8 | 14 | Jan 27, 2026 | J-GAAP |
| Revision Rate | -10.8% | -30.0% | -1.4% | +30.0% | +30.3% |
Current Period Guidance
Second Half Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jul - Dec, 2024 | 9,650 | 422 | 423 | 539 | 61.2 | 13 | Feb 13, 2025 | J-GAAP |
| Jul - Dec, 2025 Guidance | 8,625 | 148 | 215 | 399 | 45.3 | 14 | Jan 27, 2026 | J-GAAP |
| YoY | -10.6% | -64.9% | -49.2% | -26.0% | -26.0% |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Dec, 2023 | 19,042 | 742 | 811 | 573 | 64.3 | 12 | Feb 14, 2024 | J-GAAP |
| Dec, 2024 | 18,419 | 687 | 857 | 799 | 90.7 | 13 | Feb 13, 2025 | J-GAAP |
| Dec, 2025 Guidance | 17,400 | 560 | 720 | 650 | 73.8 | 14 | Jan 27, 2026 | J-GAAP |
| YoY | -5.5% | -18.5% | -16.0% | -18.6% | -18.7% |
Related Articles
CAPCOM, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 65%, Oct-Dec Ordinary Profit Increases by 42%
KOMERI, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 3%, Oct-Dec Ordinary Profit Decreases by 7%
REALGATE, Oct-Dec (1Q) Ordinary Profit Increases by 4.5 times
TESEC, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 61%
Shin-Etsu Chemical, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 13%
Cybertrust Japan, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 18%, Oct-Dec Ordinary Profit Increases by 7%
CAWACHI LIMITED, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 16%, Oct-Dec Ordinary Profit Decreases by 15%
Mirrativ, Ordinary Profit Forecast for Last Fiscal Year Revised Upward by 73%
Genky DrugStares, First Half Ordinary Profit Increases by 24%, Oct-Dec Ordinary Profit Increases by 19%
SE Holdings&Incubations, Oct-Dec (3Q) Ordinary Profit Increases by 89%, Current Fiscal Year Dividend Revised Upward by 0.5 Yen